PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.27%
Revenue growth similar to ENPH's 20.15%. Walter Schloss would see if both companies share industry tailwinds.
12.71%
Gross profit growth at 50-75% of ENPH's 23.75%. Martin Whitman would question if cost structure or brand is lagging.
-233.84%
Negative EBIT growth while ENPH is at 52.10%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-90.19%
Negative operating income growth while ENPH is at 52.10%. Joel Greenblatt would press for urgent turnaround measures.
-91.84%
Negative net income growth while ENPH stands at 48.54%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-89.47%
Negative EPS growth while ENPH is at 45.95%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-89.47%
Negative diluted EPS growth while ENPH is at 50.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.33%
Share reduction more than 1.5x ENPH's 1.50%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.33%
Slight or no buyback while ENPH is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
48.66%
OCF growth at 50-75% of ENPH's 95.87%. Martin Whitman would question if the firm lags in monetizing sales effectively.
41.15%
FCF growth under 50% of ENPH's 113.13%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-52.25%
Negative 10Y revenue/share CAGR while ENPH stands at 163.61%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
2.11%
5Y revenue/share CAGR under 50% of ENPH's 320.53%. Michael Burry would suspect a significant competitive gap or product weakness.
-21.57%
Negative 3Y CAGR while ENPH stands at 215.42%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
14.74%
10Y OCF/share CAGR under 50% of ENPH's 412.61%. Michael Burry would worry about a persistent underperformance in cash creation.
72.34%
Below 50% of ENPH's 63819.00%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
43.59%
3Y OCF/share CAGR under 50% of ENPH's 983.57%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
48.93%
Below 50% of ENPH's 287.23%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
46.04%
Below 50% of ENPH's 477.16%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-142.56%
Negative 3Y CAGR while ENPH is 478.32%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-75.77%
Negative equity/share CAGR over 10 years while ENPH stands at 78.20%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-55.61%
Negative 5Y equity/share growth while ENPH is at 11309.16%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
313.59%
3Y equity/share CAGR above 1.5x ENPH's 206.79%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
15.84%
Our AR growth while ENPH is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-9.40%
Inventory is declining while ENPH stands at 35.08%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.18%
Negative asset growth while ENPH invests at 7.68%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
16.14%
Under 50% of ENPH's 34.25%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
1.70%
Debt growth far above ENPH's 0.17%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
47.80%
R&D growth drastically higher vs. ENPH's 9.90%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
20.84%
SG&A growth well above ENPH's 7.91%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.